MedPath

Oral Glucosestimulation After Gastric Bypass Surgery

Not Applicable
Completed
Conditions
Obesity
Registration Number
NCT01851616
Lead Sponsor
University Hospital, Basel, Switzerland
Brief Summary

The objective of this study is to examine gastric emptying and satiety hormones after oral glucose stimulation in 2 different concentrations in morbidly obese patients after Roux-en-Y-gastric-Bypass.

Detailed Description

After gastric bypass many patients suffer from early and/or late dumping syndrome as a reaction to carbohydrate rich meals. Gastric emptying after bypass is accelerated and nutrition enters the intestine faster, which leads to osmotically driven fluid shifts from the blood to the lumen. Late dumping occurs 1-3 h after eating, and is caused by hyperinsulinemia and is therefore characterized by symptoms of hypoglycemia like weakness, sweating, and dizziness. Many people have both types. In most studies examining satiety hormones after oral glucose stimulation in non-operated patients, glucose loads of 50-75g are used. For a measurable GLP-1 rise a threshold of 2 kcal/min. at the intestine is needed. After gastric bypass gastric emptying is accelerated and less glucose is necessary to reach this threshold. The "threshold load" and "tolerable load without dumping symptoms" is not yet know.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
8
Inclusion Criteria
  • 6 weeks post gastric bypass surgery,
  • non-diabetic patient
Exclusion Criteria
  • smoker,
  • diabetes,
  • gastrointestinal motility disorder,
  • medication influencing gastric emptying

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
amount of oral glucose leading to increase in satiety hormones240 min.
Secondary Outcome Measures
NameTimeMethod
Amount of oral glucose leading to clinical signs of dumping240min.

Trial Locations

Locations (1)

University Hospital of Basel

🇨🇭

Basel, Switzerland

University Hospital of Basel
🇨🇭Basel, Switzerland

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.